[go: up one dir, main page]

FR3033700B1 - Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray - Google Patents

Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray

Info

Publication number
FR3033700B1
FR3033700B1 FR1552109A FR1552109A FR3033700B1 FR 3033700 B1 FR3033700 B1 FR 3033700B1 FR 1552109 A FR1552109 A FR 1552109A FR 1552109 A FR1552109 A FR 1552109A FR 3033700 B1 FR3033700 B1 FR 3033700B1
Authority
FR
France
Prior art keywords
inhibition
spray
treatment
composition
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1552109A
Other languages
English (en)
Other versions
FR3033700A1 (fr
Inventor
Jean-Claude Feydieu
Bastien Seguy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Beyond Modern Care
Original Assignee
Medical Beyond Modern Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Beyond Modern Care filed Critical Medical Beyond Modern Care
Priority to FR1552109A priority Critical patent/FR3033700B1/fr
Publication of FR3033700A1 publication Critical patent/FR3033700A1/fr
Application granted granted Critical
Publication of FR3033700B1 publication Critical patent/FR3033700B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
FR1552109A 2015-03-16 2015-03-16 Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray Expired - Fee Related FR3033700B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1552109A FR3033700B1 (fr) 2015-03-16 2015-03-16 Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1552109A FR3033700B1 (fr) 2015-03-16 2015-03-16 Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray

Publications (2)

Publication Number Publication Date
FR3033700A1 FR3033700A1 (fr) 2016-09-23
FR3033700B1 true FR3033700B1 (fr) 2017-03-17

Family

ID=53177638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1552109A Expired - Fee Related FR3033700B1 (fr) 2015-03-16 2015-03-16 Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray

Country Status (1)

Country Link
FR (1) FR3033700B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3421029A1 (fr) * 2017-06-29 2019-01-02 Lacer, S.A. Composition comprenant un antiseptique, un composé neutralisant le soufre volatile et un agent anticarie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026252A1 (fr) * 1979-09-27 1981-04-08 Blendax-Werke R. Schneider GmbH & Co. Composition pour l'hygiène orale
ES2132033B1 (es) * 1997-11-06 2000-03-01 Dentaid Sa Composicion oral para el tratamiento de la halitosis.
JP2988928B1 (ja) * 1998-12-18 1999-12-13 三井物産株式会社 口中スプレー用組成物
NO990975A (no) * 1999-03-01 2000-02-21 Orix As Oralt preparat som er effektivt mot halitose
GB0007762D0 (en) * 2000-03-30 2000-05-17 Smithkline Beckman Corp Composition
GR1005854B (el) * 2007-05-08 2008-03-20 Παναγιωτης Κλεανθη Μιλτιαδους Φυτικη υγρη οδοντοπαστα σε σπρευ η σταγονες

Also Published As

Publication number Publication date
FR3033700A1 (fr) 2016-09-23

Similar Documents

Publication Publication Date Title
EP3373972C0 (fr) Compositions pour le traitement de l'atrophie musculaire spinale
EP3426258A4 (fr) Compositions d'antibiotiques stéroïdiens cationiques pour le traitement de tissu dermique
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
EP3334499A4 (fr) Conjugués bioactifs pour l'administration d'oligonucléotides
IL286592B (en) Amino acid compounds for the treatment of liver disease
EP3298140A4 (fr) Compositions pour le traitement d'états de calcification pathologique, et méthodes les utilisant
MA44875A (fr) Compositions pour le traitement de troubles acido-basiques
MA43800A (fr) Octréotide par voie orale pour le traitement de maladies
EP3495118A4 (fr) Composition d'agent de traitement pour précurseur d'objet tridimensionnel
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
IL268905B (en) Phage therapy
MA45552A (fr) Compositions destinées au traitement de l'amylose
EP3419981A4 (fr) Polythérapies utilisées dans le traitement de l'amyotrophie spinale
EP3344650A4 (fr) Aav-epo pour le traitement d'animaux de compagnie
EP3632431A4 (fr) Agent de prévention ou de traitement de l'atrophie cérébrale
EP3373922A4 (fr) Compositions et méthodes pour le traitement de l'homocystinurie
HK1243709A1 (zh) 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物
EP3354284A4 (fr) Composition pour le traitement de la douleur
FR3033700B1 (fr) Composition de traitement ou d'inhibition d'une mauvaise haleine par voie orale sous la forme d'un spray
EP3405174A4 (fr) Formulation de bêtaméthasone destinée à une pulvérisation par voie orale et méthode d'utilisation associée pour le traitement de l'ataxie
IT201600122310A1 (it) Composizione per uso nella terapia di alterazioni dell'intestino
MA49375A (fr) Composition pour le traitement de la blépharite
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
EP3532081C0 (fr) Composition pour le traitement préventif ou curatif de troubles hépatiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Search report ready

Effective date: 20160923

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20191106